4.8 Editorial Material

Isavuconazole: a role for the newest broad-spectrum triazole

Journal

LANCET
Volume 387, Issue 10020, Pages 726-728

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(15)01218-0

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Computer Science, Interdisciplinary Applications

Detecting evidence of invasive fungal infections in cytology and histopathology reports enriched with concept-level annotations

Vlada Rozova, Anna Khanina, Jasmine C. Teng, Joanne S. K. Teh, Leon J. Worth, Monica A. Slavin, Karin A. Thursky, Karin Verspoor

Summary: Invasive fungal infections (IFIs) pose significant risks to high-risk patients and hinder cancer therapy. Surveillance of IFI in clinical settings offers potential for identifying risk factors and evaluating new treatments. By using natural language processing (NLP) on pathology reports, we developed an automated system for detecting IFI evidence and achieved improved performance by extracting targeted information.

JOURNAL OF BIOMEDICAL INFORMATICS (2023)

Review Infectious Diseases

Predicting infections in patients with haematological malignancies treated with chimeric antigen receptor T-cell therapies: A systematic scoping review and narrative synthesis

Gemma Reynolds, Beatrice Sim, Mary Ann Anderson, Tim Spelman, Benjamin W. Teh, Monica A. Slavin, Karin A. Thursky

Summary: CAR-T-treated patients with haematological malignancies are at risk of infections, with prior therapies, neutropenia, steroid administration, and immuneeffector cell-associated neurotoxicity being the most associated risk factors. Biochemical markers and cytokine profiles do not reliably predict infections. Predictors of viral, bacterial, and fungal infections are poorly studied.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Review Infectious Diseases

The antifungal pipeline for invasive fungal diseases: what does the future hold?

Chin Fen Neoh, Wirawan Jeong, David C. M. Kong, Monica A. Slavin

Summary: In the past two decades, there have been urgent needs for new antifungal agents due to the emergence of resistant fungi, the growing at-risk patient populations for invasive fungal diseases (IFD), and the high morbidity and mortality associated with IFD. This review discusses five promising antifungal agents for IFD (i.e. fosmanogepix, ibrexafungerp, olorofim, rezafungin, and opelconazole), currently in late-phase clinical studies and likely to be available for clinical use soon. The mechanisms of action, pharmacokinetic and pharmacodynamic properties, spectrum of activity, safety, and efficacy data of each agent, including ongoing clinical trials, are described. The potential roles of these novel antifungals in clinical practice and the key considerations for clinical use are also discussed.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2023)

Article Infectious Diseases

Validation of the Antifungal National Antimicrobial Prescribing Survey (AF-NAPS) quality assessment tool

A. Khanina, A. P. Douglas, D. K. Yeoh, M. So, J. Abbotsford, T. Spelman, D. C. M. Kong, M. A. Slavin, K. A. Thursky

Summary: The Antifungal National Antimicrobial Prescribing Survey (AF-NAPS) tool was assessed for its validity and reliability. The tool was found to be generally accurate, but some incorrect classifications were identified. The aim is to address the reasons for incorrect classification through online tools and educational materials.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Review Immunology

Invasive aspergillosis in liver transplant recipients

Clea Melenotte, Vishukumar Aimanianda, Monica Slavin, Jose Maria Aguado, Darius Armstrong-James, Yee-Chun Chen, Shahid Husain, Christian Van Delden, Faouzi Saliba, Agnes Lefort, Francoise Botterel, Olivier Lortholary

Summary: Invasive aspergillosis is a rare but serious infection in liver transplant recipients, with a high mortality rate. Risk factors before, during, and after transplantation have been identified, and accurate diagnosis requires collaboration between radiology and clinical biology. It is recommended to reduce the dose of tacrolimus and closely monitor blood levels when using certain drugs, and surgery should be considered on a case-by-case basis. Antifungal prophylaxis and environmental measures should be implemented to prevent outbreaks.

TRANSPLANT INFECTIOUS DISEASE (2023)

Article Public, Environmental & Occupational Health

Identifying barriers and enablers to participation in infection surveillance in Australian residential aged care facilities

Eliza Watson, Leslie Dowson, David Dunt, Karin Thursky, Leon J. Worth, Janet K. Sluggett, Amanda Appathurai, Noleen Bennett

Summary: The study identified barriers to participation in aged care infection surveillance programs, such as time-consuming data collection, competing tasks, limited understanding among some staff, difficulty engaging clinicians, and staff fatigue post-COVID-19. Enablers included previous experience with surveillance, sharing responsibilities, educational materials, and using data for benchmarking and practice improvement.

BMC PUBLIC HEALTH (2023)

Article Computer Science, Information Systems

Evaluating the accuracy and efficacy of an electronic medical record alert to identify paediatric patients with low-risk febrile neutropenia

Claudia Corrente, Saravanan Satkumaran, Ahuva Segal, Coen Butters, Corinne Fernandez, Franz E. Babl, Lisa M. Orme, Karin Thursky, Gabrielle M. Haeusler

Summary: This study evaluated the accuracy and impact of a clinical-facing best practice advisory (BPA) embedded into an electronic medical record workflow. The results showed poor sensitivity and limited impact on clinician behavior, indicating the need for improvement.

INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS (2023)

Editorial Material Immunology

Parvovirus B19 in stem cell transplantation

Paul M. Kinsella, Michelle K. Yong, Monica A. Slavin, Victoria G. Hall

TRANSPLANT INFECTIOUS DISEASE (2023)

Editorial Material Immunology

Goals to score: The need for a minimum reporting dataset in studies of infection events in immunocompromised patients

Benjamin W. Teh, Malgorzata Mikulska, Nicolas J. Mueller, Monica A. Slavin

TRANSPLANT INFECTIOUS DISEASE (2023)

Review Immunology

Fluoroquinolone prophylaxis in patients with neutropenia at high risk of serious infections: Exploring pros and cons

Nikhil Singh, Karin Thursky, Gabriela Maron, Joshua Wolf

TRANSPLANT INFECTIOUS DISEASE (2023)

Review Immunology

CMV prevention strategies in allogeneic hematopoietic cell transplantation; the role of prophylaxis and pre-emptive monitoring in the era of letermovir

Michelle K. Yong, Monica A. Slavin, Roy F. Chemaly, Genovefa A. Papanicolaou

Summary: In recent years, there has been a significant shift in the preferred strategy for preventing CMV in at-risk populations in alloHCT. Letermovir prophylaxis is now offered to all CMV seropositive recipients, resulting in significant reductions in CMV infection and other important outcomes. However, there are limitations such as delayed onset CMV infections and increased drug costs.

TRANSPLANT INFECTIOUS DISEASE (2023)

Article Hematology

American Society for Transplantation and Cellular Therapy Series, #6: Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients

Dionysios Neofytos, William J. Steinbach, Kimberly Hanson, Paul A. Carpenter, Genovefa A. Papanicolaou, Monica A. Slavin

Summary: The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy (ASTCT) updated their infectious disease guidelines for hematopoietic cell transplantation (HCT) by publishing concise formats of frequently asked questions, tables, and figures. This sixth guideline focuses on invasive candidiasis (IC) and addresses its epidemiology, clinical diagnosis, prophylaxis, and treatment, along with special considerations for different types of HCT recipients and future research directions.

TRANSPLANTATION AND CELLULAR THERAPY (2023)

Article Infectious Diseases

Costs associated with invasive Scedosporium and Lomentospora prolificans infections: a case-control study

Chin Fen Neoh, Sharon C. A. Chen, David C. M. Kong, Kate Hamilton, Quoc A. Nguyen, Tim Spelman, Michelle Tew, Emma L. Harvey, Su Ann Ho, Natalie R. Saunders, Surekha Tennakoon, Amy Crowe, Debbie Marriott, Jason A. Trubiano, Monica A. Slavin

Summary: The economic burden of invasive Scedosporium/L. prolificans infections is substantial, with an adjusted median excess cost of AUD36,422 and a length of stay of 16.27 days during index hospitalization. The cumulative cost can increase significantly to AUD203,292 over 1.5 years in cases with these infections.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Review Immunology

Approach to diagnostic evaluation and prevention of invasive fungal disease in patients prior to allogeneic hematopoietic stem cell transplant

Jessica C. O'Keeffe, Nikhil Singh, Monica A. Slavin

Summary: This review provides a comprehensive overview of pretransplant workup, identification, and prevention of invasive fungal diseases (IFDs) in patients with hematological malignancy. Assessing risk factors and implementing appropriate prophylactic measures during the pretransplant period are essential for effectively preventing IFD.

TRANSPLANT INFECTIOUS DISEASE (2023)

No Data Available